-
Essien Receives Two Awards
CP3 Faculty Affiliate Dr. Utibe Essien has been honored with two recent awards: American Diabetes Association 2021 Early Career Investigator Award and VA HSR&D Career Development Award. Congrats, Dr. Essien!
Learn more about Dr. Essien's work here -
Hernandez Receives Hersh Emerging Leader Award
Former CP3 Associate Director Dr. Inma Hernandez received the Alice S. Hersh Emerging Leader Award at the Academy Health 2021 Annual Research Meeting, for her past and potential contributions to health services research. Dr. Hernandez was nominated by her mentor, CP3 Director Dr. Walid Gellad.
Read more about the award -
Suda New Associate Director
With former CP3 Associate Director Dr. Inma Hernandez's departure from Pitt to UCSD, we've appointed Faculty Affiliate Dr. Katie Suda as our new Associate Director. Congratulations!
Read more about Dr. Suda's work here -
NASEM Report Release
Many expensive drugs are distributed in single-dose vials. What are implications of discarding the excess? CP3 Faculty Affiliate Dr. Julie Donohue was part of the NASEM committee to report the findings.
Read the report here
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
